查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年按類型（細胞分離、組織分離）、按產品（酶解離）、按最終用途、按地區、按細分市場劃分的細胞解離市場規模、份額、趨勢分析報告
市場調查報告書
商品編碼
1233239

2023-2030 年按類型（細胞分離、組織分離）、按產品（酶解離）、按最終用途、按地區、按細分市場劃分的細胞解離市場規模、份額、趨勢分析報告

Cell Dissociation Market Size, Share & Trends Analysis Report By Type (Cell Detachment, Tissue Dissociation), By Product (Enzymatic Dissociation), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

細胞解離市場的增長和趨勢

Grand View Research, Inc. 的一份新報告預測，到 2030 年，全球細胞解離市場規模將達到 8.633 億美元，複合年增長率為總收入的 13.55%。預計。

慢性病和傳染病患病率的上升以及對基於細胞的療法的日益關注正在推動市場的增長。 此外，增加對基於細胞的研究的資助和增加自動化儀器的使用是推動該行業發展的主要因素。 隨著越來越多地使用患者來源的細胞作為研究模型系統，對高質量細胞材料的需求也在不斷發展。 從組織中提取單個細胞的能力目前是基於細胞的診斷技術的瓶頸，並且在組織工程、新型診斷、癌症研究和個性化醫學方法領域仍然至關重要。

主要挑戰是細胞質量和產量、純度和完整性、重現性和通量。 為了克服這些限制，Institut fur Politikwissenschaft 的研究人員正在開發一種機械組織分解系統，該系統基於集成到標準 50 毫升離心管中的反向旋轉磨牙。 COVID-19 大流行對市場增長產生了積極影響。 細胞解離和組織解離主要用於支持間充質基質細胞 (MSC) 的細胞療法。 因此，COVID-19 流行病增加了這些酶的使用，推動了市場增長。 近年來，幹細胞治療已成為前沿和有前途的科研課題。

治療學的發展提供了巨大的機遇。 幹細胞具有成為醫學最重要方面之一的巨大潛力。 幹細胞不僅會在恢復性療法的開發中發揮重要作用，它們的研究還將揭示有關人類發育過程中發生的複雜事件的新信息。 此外，不僅細胞培養廣泛用於研究幹細胞生物學的基礎研究，而且培養的干細胞的治療應用也被期待，因此人們對改進乾細胞培養的興趣越來越大。 解離在各種研究和治療應用中起著重要作用，例如藥物發現、開發和細胞治療。

此外，增加臨床試驗、FDA 批准以及主要參與者合作等戰略舉措正在推動行業發展。 例如，2021年10月，總部位於德國專注於創新幹細胞療法臨床開發的生物製藥公司RHEACELL，其細胞治療產品AMESANAR獲得了德國藥品法規定的國內批准。 2023年2月， IASO Biotherapeutics 獲得美國食品藥品監督管理局（USFDA）授予的用於治療復發/難治性多發性骨髓瘤的 IND BCMA CAR-T CT103A 的先進再生醫學指定和快速通道指定。 對原材料的嚴格監管和與動物源性產品相關的倫理問題可能會在一定程度上阻礙行業發展。

製造細胞療法產品的指南仍在製定中。 然而，相關文件是USP 1046，其中規定了製造過程中使用的原材料的資格。 因此，考慮成分一致性、來源、雜質風險以及成分是否根據 GMP 指南生產等問題對批准有影響。 然而，在預測期內，對非動物源性 GMP 級酶的興趣日益增長，預計將推動行業增長。 由於慢性病發病率高、政府對細胞治療的資助增加以及實驗室和臨床研究的質量基礎設施的存在，北美在 2022 年主導了全球產業。

細胞解離市場報告要點

  • 由於酶解產品在製藥和生物技術公司中的需求和重要性不斷增加，酶解產品部分將在 2022 年佔據最高份額，從而導致該部分的加速採用和增長預計會增加。
  • 由於研發活動的增加和慢性病的高患病率，組織解離類型在 2022 年佔了最大的收入份額。
  • 生物製藥和製藥公司的最終用戶部門將在 2022 年引領行業發展，這得益於細胞療法臨床試驗的增加、FDA 的批准以及對細胞和基因療法的研究。
  • 亞太地區有望在預測期內實現最快的增長率。
  • 這是由於對新療法的需求不斷增長以及基礎設施的快速發展。

內容

第一章研究方法論

  • 市場細分和範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法逐個國家/地區進行市場估算
  • 全球市場：CAGR 計算
  • 調查假設
  • 二級信息列表
  • 主要信息列表
  • 目的
  • 縮寫列表

第二章市場定義

第 3 章執行摘要

  • 市場概覽

第 4 章全球細胞解離市場變量、趨勢和範圍

  • 細胞解離市場譜系展望
    • 母公司市場展望
  • 描繪滲透率和增長前景
  • 市場驅動因素分析
    • 對開發基於細胞的療法的興趣與日俱增
    • 增加對細胞研究的資助
    • 細胞解離裝置技術進展
  • 市場製約因素分析
    • 嚴格的規定
  • 市場機會分析
    • 越來越關注幹細胞研究
  • 波特的五力分析
  • 細胞解離市場：COVID-19 影響分析

第 5 章細胞解離市場 - 細分分析，副產品，2018-2030（百萬美元）

  • 全球細胞解離市場：產品差異分析
  • 酶解
    • 胰蛋白酶
    • 膠原酶
    • 彈性蛋白酶
    • 木瓜蛋白酶
    • 透明質酸酶
    • DNase
    • 其他
  • 非酶解
  • 設備和配件

第 6 章細胞解離市場 - 細分分析，按類型，2018-2030（百萬美元）

  • 全球細胞解離市場：類型變異分析
  • 組織解離
  • 細胞分離

第 7 章細胞解離市場 - 細分分析，按最終用途，2018-2030（百萬美元）

  • 細胞解離市場：最終用戶差異分析
  • 製藥和生物技術公司
  • 研究和學術機構

第 8 章細胞解離市場：-按地區劃分的細分分析，2018-2030 年（百萬美元）

  • 細胞解離市場：區域差異分析
  • 北美
    • SWOT 分析
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
  • 歐洲
    • SWOT 分析
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
  • 亞太地區
    • SWOT 分析
    • 日本
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 中國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 印度
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 韓國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 澳大利亞
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 泰國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
  • 拉丁美洲
    • SWOT 分析
    • 巴西
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 墨西哥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 阿根廷
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
  • 多邊環境協定
    • SWOT 分析
    • 南非
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 沙特阿拉伯
      • 主要國家動態
      • 目標疾病的患病率
      • 衝突設想
      • 監管框架
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
    • 科威特
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架

第9章競爭格局

  • 公司分類
  • 公司市場定位
  • 2022 年公司市場份額分析
  • 公司熱圖分析
  • 戰略規劃
  • 公司簡介/列表
    • Thermo Fisher Scientific Inc.
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • Danaher Corporation
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • STEMCELL Technologies
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • Merck KGaA
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • BD
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • Sartorius AG
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • Miltenyi Biotec
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • PAN-Biotech
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • HiMedia Laboratories
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • F. Hoffmann-La Roche Ltd
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
    • S2 Genomics, Inc.
      • 概覽
      • 財務業績（淨收入/銷售額/EBITDA/毛利）
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-037-4

Cell Dissociation Market Growth & Trends:

The global cell dissociation market size is expected to reach USD 863.3 million by 2030, registering a CAGR of 13.55% of the overall revenue, according to a new report by Grand View Research, Inc. The rising prevalence of chronic and infectious diseases, coupled with the increasing focus on cell-based therapeutics, is boosting market growth. In addition, growing funding for cell-based research and increasing use of automated instruments are the key factors driving the industry. With the growing applications of patient-derived cells as a model system for research, the necessity for high-quality cell material is constantly developing. The capability to extract individual cells from tissues is presently a bottleneck for cell-based diagnostic technologies and remains vital in the areas of tissue engineering, emerging diagnostic methods, cancer research, and personalized medicine approaches.

Key challenges comprise the quality and yield or the purity and integrity of cells as well as reproducibility and throughput. To overcome these limitations, researchers from Institut fur Politikwissenschaft are developing a mechanical tissue dissociation system based on counter-rotating rows of grinding teeth integrated into a standard 50 ml centrifuge tube. The COVID-19 pandemic influenced market growth positively. Cell dissociation and tissue dissociation are used to aid cell-based therapies, primarily using Mesenchymal Stromal Cells (MSCs). As a result, the usage of these enzymes increased due to the COVID-19 pandemic, which augmented market growth. In current years, stem cell therapy has become an advanced and promising scientific research topic.

The development of treatment methods has induced great opportunities. Stem cells have considerable potential to become one of the most significant aspects of medicine. In addition to the fact that they play a huge role in developing restorative therapy, their study also divulges additional information about the complex events that happen during human development. Moreover, there is a growing interest in improving stem cell culture, not only because cell culture is extensively used in basic research for studying stem cell biology but also due to the potential therapeutic applications of cultured stem cells. Dissociation plays an important role in various research and therapeutic applications, including drug discovery, development, and cell therapy.

Furthermore, increasing clinical trials, FDA approvals, and strategic initiatives, such as collaborations by major players, are boosting industry growth. For instance, in October 2021, RHEACELL, a biopharmaceutical company headquartered in Germany, focused on the clinical development of innovative stem cell therapeutics, received national approval under the German Medicinal Products Act for its cell therapy product AMESANAR. In February 2023, IASO Biotherapeutics received Regenerative Medicine Advanced Therapy designation and Fast Track designation from USFDA for its IND BCMA CAR-T CT103A for relapsed/refractory multiple myeloma. Stringent regulations for raw materials and ethical issues concerning animal-derived products might hamper the industry's growth to a certain extent.

The guidelines for the manufacturing of cell therapy products are still progressing. Still, the relevant reference is the USP 1046, which designates the significance of qualifying raw materials used in the manufacturing process. Thus, considering the concerns, such as raw material consistency, origin, risk of impurity, and whether the raw material was manufactured under the GMP guidelines, is significant for approval. However, there is a growing interest in Animal-origin free and GMP-grade enzymes, which will drive the industry growth during the forecast period. North America dominated the global industry in 2022 due to the high incidence of chronic diseases, the rise in investment funding by the government for cell therapy, and the presence of high-quality infrastructure for laboratory and clinical research.

Cell Dissociation Market Report Highlights:

  • The enzymatic dissociation product segment accounted for the highest share in 2022 due to increased requirements and the importance of enzymatic dissociation products for pharmaceutical & biotechnology companies, which, in turn, is likely to boost the adoption and anticipate the segment growth
  • The tissue dissociation type segment held the largest revenue share in 2022 owing to the increased R&D activities and high prevalence of chronic disorders
  • The biopharmaceutical & pharmaceutical companies end-user segment led the industry in 2022 owing to growth in clinical trials of cell-based therapeutics, FDA approvals, and research on cell & gene therapy
  • The Asia Pacific region is expected to register the fastest growth rate during the forecast period
  • This is owing to the rising demand for novel therapeutics and rapid infrastructural development

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global Cell Dissociation Market Variables, Trends, & Scope

  • 4.1 Cell Dissociation Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration And Growth Prospect Mapping
  • 4.3 Market Driver Analysis
    • 4.3.1 Rising Focus On The Development Of Cell-Based Therapeutics
    • 4.3.2 Growing Funding For Cell-Based Research
    • 4.3.3 Technological Advancements In Cell Dissociations Instruments
  • 4.4 Market Restraint Analysis
    • 4.4.1 Stringent Regulations
  • 4.5 Market Opportunity Analysis
    • 4.5.1 Growing Emphasis On Stem Cell Research
  • 4.6 Porter's Five Forces Analysis
  • 4.7 Cell Dissociation Market: COVID-19 Impact Analysis

Chapter 5 Cell Dissociation Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 5.1 Global Cell Dissociation Market: Product Movement Analysis
  • 5.2 Enzymatic Dissociation
    • 5.2.1 Enzymatic Dissociation market estimates and forecast, 2018-2030, USD million
    • 5.2.2 Trypsin
      • 5.2.2.1 Trypsin market estimates and forecast, 2018-2030, USD million
    • 5.2.3 Collagenase
      • 5.2.3.1 Collagenase market estimates and forecast, 2018-2030, USD million
    • 5.2.4 Elastase
      • 5.2.4.1 Elastase market estimates and forecast, 2018-2030, USD million
    • 5.2.5 Papain
      • 5.2.5.1 Papain market estimates and forecast, 2018-2030, USD million
    • 5.2.6 Hyaluronidase
      • 5.2.6.1 Hyaluronidase market estimates and forecast, 2018-2030, USD million
    • 5.2.7 DNase
      • 5.2.7.1 DNase market estimates and forecast, 2018-2030, USD million
    • 5.2.8 Others
      • 5.2.8.1 Others market estimates and forecast, 2018-2030, USD million
  • 5.3 Non-Enzymatic Dissociation
    • 5.3.1 Non-Enzymatic dissociation market estimates and forecast, 2018-2030, USD million
  • 5.4 Instruments & Accessories
    • 5.4.1 Instruments & accessories market estimates and forecast, 2018-2030, USD million

Chapter 6 Cell Dissociation Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 6.1 Global Cell Dissociation Market: Type Movement Analysis
  • 6.2 Tissue Dissociation
    • 6.2.1 Tissue dissociation market estimates and forecast, 2018-2030, USD million
  • 6.3 Cell Detachment
    • 6.3.1 Cell detachment market estimates and forecast, 2018-2030, USD million

Chapter 7 Cell Dissociation Market- Segment Analysis, by End-user, 2018 - 2030 (USD Million)

  • 7.1 Cell Dissociation Market: End-user Movement Analysis
  • 7.2 Pharmaceutical And Biotechnology Companies
    • 7.2.1 Pharmaceutical And Biotechnology Companies market estimates and forecast, 2018-2030, USD million
  • 7.3. Research & Academic Institutes
    • 7.3.1 Research & academic institutes market estimates and forecast, 2018-2030, USD million

Chapter 8 Cell Dissociation Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Cell Dissociation Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 SWOT analysis
      • 8.2.1.1 North America cell dissociation market, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key country dynamics
      • 8.2.2.2 Target disease prevalence
      • 8.2.2.3 Competitive scenario
      • 8.2.2.4 Regulatory framework
      • 8.2.2.5 U.S. cell dissociation market, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Key country dynamics
      • 8.2.3.2 Target disease prevalence
      • 8.2.3.3 Competitive scenario
      • 8.2.3.4 Regulatory framework
      • 8.2.3.5 Canada cell dissociation market, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 SWOT Analysis
      • 8.3.1.1 Europe cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Key country dynamics
      • 8.3.2.2 Target disease prevalence
      • 8.3.2.3 Competitive scenario
      • 8.3.2.4 Regulatory framework
      • 8.3.2.5 Germany cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 Key country dynamics
      • 8.3.3.2 Target disease prevalence
      • 8.3.3.3 Competitive scenario
      • 8.3.3.4 Regulatory framework
      • 8.3.3.5 U.K. cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 Key country dynamics
      • 8.3.4.2 Target disease prevalence
      • 8.3.4.3 Competitive scenario
      • 8.3.4.4 Regulatory framework
      • 8.3.4.5 France cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Key country dynamics
      • 8.3.5.2 Target disease prevalence
      • 8.3.5.3 Competitive scenario
      • 8.3.5.4 Regulatory framework
      • 8.3.5.5 Italy cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Key country dynamics
      • 8.3.6.2 Target disease prevalence
      • 8.3.6.3 Competitive scenario
      • 8.3.6.4 Regulatory framework
      • 8.3.6.5 Spain cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.7 Denmark
      • 8.3.7.1 Key country dynamics
      • 8.3.7.2 Target disease prevalence
      • 8.3.7.3 Competitive scenario
      • 8.3.7.4 Regulatory framework
      • 8.3.7.5 Denmark cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.8 Sweden
      • 8.3.8.1 Key country dynamics
      • 8.3.8.2 Target disease prevalence
      • 8.3.8.3 Competitive scenario
      • 8.3.8.4 Regulatory framework
      • 8.3.8.5 Sweden cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.9 Norway
      • 8.3.9.1 Key country dynamics
      • 8.3.9.2 Target disease prevalence
      • 8.3.9.3 Competitive scenario
      • 8.3.9.4 Regulatory framework
      • 8.3.9.5 Norway cell dissociation market, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 SWOT Analysis
      • 8.4.1.1 Asia Pacific cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key country dynamics
      • 8.4.2.2 Target disease prevalence
      • 8.4.2.3 Competitive scenario
      • 8.4.2.4 Regulatory framework
      • 8.4.2.5 Japan cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 Key country dynamics
      • 8.4.3.2 Target disease prevalence
      • 8.4.3.3 Competitive scenario
      • 8.4.3.4 Regulatory framework
      • 8.4.3.5 China cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 Key country dynamics
      • 8.4.4.2 Target disease prevalence
      • 8.4.4.3 Competitive scenario
      • 8.4.4.4 Regulatory framework
      • 8.4.4.5 India cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 Key country dynamics
      • 8.4.5.2 Target disease prevalence
      • 8.4.5.3 Competitive scenario
      • 8.4.5.4 Regulatory framework
      • 8.4.5.5 South Korea cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.3.9.1 Key country dynamics
      • 8.4.6.2 Target disease prevalence
      • 8.4.6.3 Competitive scenario
      • 8.4.6.4 Regulatory framework
      • 8.4.6.5 Australia cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.7 Thailand
      • 8.4.7.1 Key country dynamics
      • 8.4.7.2 Target disease prevalence
      • 8.4.7.3 Competitive scenario
      • 8.4.7.4 Regulatory framework
      • 8.4.7.5 Thailand cell dissociation market, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 SWOT Analysis
      • 8.5.1.1 Latin America cell dissociation market, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key country dynamics
      • 8.5.2.2 Target disease prevalence
      • 8.5.2.3 Competitive scenario
      • 8.5.2.4 Regulatory framework
      • 8.5.2.5 Brazil cell dissociation market, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Key country dynamics
      • 8.5.3.2 Target disease prevalence
      • 8.5.3.3 Competitive scenario
      • 8.5.3.4 Regulatory framework
      • 8.5.3.5 Mexico cell dissociation market, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Key country dynamics
      • 8.5.4.2 Target disease prevalence
      • 8.5.4.3 Competitive scenario
      • 8.5.4.4 Regulatory framework
      • 8.5.4.5 Argentina cell dissociation market, 2018 - 2030 (USD Million)
  • 8.6 MEA
    • 8.6.1 SWOT Analysis
      • 8.6.1.1 MEA cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.4.1 Key country dynamics
      • 8.6.2.2 Target disease prevalence
      • 8.6.2.3 Competitive scenario
      • 8.6.2.4 Regulatory framework
      • 8.6.2.5 South Africa cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key country dynamics
      • 8.6.3.2 Target disease prevalence
      • 8.6.3.3 Competitive scenario
      • 8.6.3.4 Regulatory framework
      • 8.6.3.5 Saudi Arabia cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 Key country dynamics
      • 8.6.4.2 Target disease prevalence
      • 8.6.4.3 Competitive scenario
      • 8.6.4.4 Regulatory framework
      • 8.6.4.5 UAE cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.5 Kuwait
      • 8.6.5.1 Key country dynamics
      • 8.6.5.2 Target disease prevalence
      • 8.6.5.3 Competitive scenario
      • 8.6.5.4 Regulatory framework
      • 8.6.5.5 Kuwait cell dissociation market, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Company Market Positioning
  • 9.3 Company Market Share Analysis, 2022
  • 9.4 Company Heat Map Analysis
  • 9.5 Strategy Mapping
  • 9.6 Company Profiles/Listing
    • 9.6.1 Thermo Fisher Scientific Inc.
      • 9.6.1.1. Overview
      • 9.6.1.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.1.3. Product benchmarking
      • 9.6.1.4. Strategic initiatives
    • 9.6.2 Danaher Corporation
      • 9.6.2.1. Overview
      • 9.6.2.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.2.3. Product benchmarking
      • 9.6.2.4. Strategic initiatives
    • 9.6.3 STEMCELL Technologies
      • 9.6.3.1. Overview
      • 9.6.3.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.3.3. Product benchmarking
      • 9.6.3.4. Strategic initiatives
    • 9.6.4 Merck KGaA
      • 9.6.4.1. Overview
      • 9.6.4.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.4.3. Product benchmarking
      • 9.6.4.4. Strategic initiatives
    • 9.6.5 BD
      • 9.6.5.1. Overview
      • 9.6.5.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.5.3. Product benchmarking
      • 9.6.5.4. Strategic initiatives
    • 9.6.6 Sartorius AG
      • 9.6.6.1. Overview
      • 9.6.6.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.6.3. Product benchmarking
      • 9.6.6.4. Strategic initiatives
    • 9.6.7 Miltenyi Biotec
      • 9.6.7.1. Overview
      • 9.6.7.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.7.3. Product benchmarking
      • 9.6.7.4. Strategic initiatives
    • 9.6.8 PAN-Biotech
      • 9.6.8.1. Overview
      • 9.6.8.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.8.3. Product benchmarking
      • 9.6.8.4. Strategic initiatives
    • 9.6.9 HiMedia Laboratories
      • 9.6.9.1. Overview
      • 9.6.9.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.9.3. Product benchmarking
      • 9.6.9.4. Strategic initiatives
    • 9.6.10 F. Hoffmann-La Roche Ltd
      • 9.6.10.1. Overview
      • 9.6.10.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.10.3. Product benchmarking
      • 9.6.10.4. Strategic initiatives
    • 9.6.11 S2 Genomics, Inc.
      • 9.6.11.1. Overview
      • 9.6.11.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.11.3. Product benchmarking
      • 9.6.11.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 4. Global cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 5. Global cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 6. Global cell dissociation market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 9. North America cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 10. North America cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 11. U.S. Cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 12. U.S. Cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 13. U.S. Cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 14. Canada cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 15. Canada cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 16. Canada cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 17. Europe cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 18. Europe cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 19. Europe cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 20. Europe cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 21. U.K. cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 22. U.K. cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 23. U.K. cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 24. Germany cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 25. Germany cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 26. Germany cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 27. France cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 28. France cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 29. France cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 30. Italy cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 31. Italy cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 32. Italy cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 33. Spain cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 34. Spain cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 35. Spain cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 36. Denmark cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 37. Denmark cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 38. Denmark cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 39. Sweden cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 40. Sweden cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 41. Sweden cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 42. Norway cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 43. Norway cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 44. Norway cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 48. Asia pacific cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 49. China cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 50. China cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 51. China cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 52. India cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 53. India cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 54. India cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 55. Japan cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 56. Japan cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 57. Japan cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 58. Thailand cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 59. Thailand cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 60. Thailand cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 61. Australia cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 62. Australia cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 63. Australia cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 64. South Korea cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 65. South Korea cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 66. South Korea cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 67. Latin America cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 68. Latin America cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 69. Latin America cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 70. Latin America cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 71. Brazil cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 72. Brazil cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 73. Brazil cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 74. Mexico cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 75. Mexico cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 76. Mexico cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 77. Argentina cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 78. Argentina cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 79. Argentina cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 84. South Africa cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 85. South Africa cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 86. South Africa cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 90. UAE cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 91. UAE cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 92. UAE cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 93. Kuwait cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 94. Kuwait cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 95. Kuwait cell dissociation market, end-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cell dissociation, market segmentation
  • Fig. 8 Market snapshot, 2021
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Market penetration vs growth prospect mapping, 2021
  • Fig. 16 Global cell dissociation market: product movement analysis
  • Fig. 17 Global cell dissociation market, for enzymatic dissociation, 2018 - 2030 (USD Million)
  • Fig. 18 Global cell dissociation market, for trypsin, 2018 - 2030 (USD Million)
  • Fig. 19 Global cell dissociation market, for collagenase, 2018 - 2030 (USD Million)
  • Fig. 20 Global cell dissociation market, for elastase, 2018 - 2030 (USD Million)
  • Fig. 21 Global cell dissociation market, for papain, 2018 - 2030 (USD Million)
  • Fig. 22 Global cell dissociation market, for hyaluronidase, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell dissociation market, for DNase, 2018 - 2030 (USD Million)
  • Fig. 24 Global cell dissociation market, for others, 2018 - 2030 (USD Million)
  • Fig. 25 Global cell dissociation market, for non-enzymatic dissociation, 2018 - 2030 (USD Million)
  • Fig. 26 Global cell dissociation market, for instruments & accessories, 2018 - 2030 (USD Million)
  • Fig. 27 Global cell dissociation market: type movement analysis
  • Fig. 28 Global cell dissociation market, for tissue dissociation, 2018 - 2030 (USD Million)
  • Fig. 29 Global cell dissociation market, for cell detachment, 2018 - 2030 (USD Million)
  • Fig. 30 Global cell dissociation market: end-user movement analysis
  • Fig. 31 Global cell dissociation market, for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 32 Global cell dissociation market, for research and academics institutes, 2018 - 2030 (USD Million)
  • Fig. 33 Regional marketplace: key takeaways
  • Fig. 34 Regional outlook, 2022 & 2030
  • Fig. 35 Global flow cytometry market: region movement analysis
  • Fig. 36 North America cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 40 U.K. cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 42 France cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia pacific cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 49 China cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 50 India cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait cell dissociation market, 2018 - 2030 (USD Million)